Skip to content

Share Buybacks at other companies

Abbott logo
AbbottABT
$180M-35.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$47.8M-53.1%
TFX
TeleflexTFX
$0-100%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$3B+50.0%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$297.6M+123%
Danaher logo
DanaherDHR
$0-100%

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.0%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.6%
Free cash flow$546.0M

Valuation

See full
Market cap$42.96B-12.6%
Enterprise value$56.65B-14.0%
P/E37.8×+6.7×
P/S-0.4×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's share buybacks?
Becton, Dickinson and Company (BDX) reported share buybacks of $2B in Q1 2026.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.